Who Is This For
Who May Be a Good Fit for Cagrilintide?
- Are interested in an investigational metabolic option that works through the amylin pathway rather than relying only on GLP-1 signaling.
- Want to explore a combination approach with a clinician rather than using a single metabolic pathway.
- Have already used an incretin-based program and experienced a plateau, and want to discuss whether a different mechanism may be relevant.
- Are interested in appetite and fullness signaling as part of a broader medically supervised weight-management strategy.
- Understand that cagrilintide is investigational for this use and is not being presented as an FDA-approved weight-loss treatment.
- Are comfortable discussing both standalone and combination approaches based on current human trial data.
- Are willing to complete a full health intake and clinical review before any treatment decision is made.
- Understand that published weight-loss percentages are trial averages, not a prediction of your individual outcome.
Cagrilintide May Not Be Appropriate If You:
- Want only an FDA-approved, established weight-management treatment.
- Are uncomfortable with investigational therapies or the uncertainty that comes with them.
- Expect the 11.8% standalone or 22.7% combination trial averages to represent a guaranteed personal result.
- Want to purchase it directly without completing an intake and provider evaluation.
- Have a medical history or other clinical factor that leads the treating provider to determine that the program is not appropriate for you.
Not Sure Whether a Combination Approach Makes Sense?
Cagrilintide works through a different pathway from GLP-1 therapies, which is why it is being studied both alone and in combination. In the REDEFINE 1 data cited in your program, the combination with semaglutide produced a higher average weight reduction than either component alone, but these remain trial averages and the program is investigational for this use.
Start with an intake so our clinical team can review your current treatment history, goals, medical background, and whether an investigational combination approach is appropriate to discuss.
